N-Acetylimidazolidinone → HCID 71253031, compound

HRID 2411959Notes

Reaction equation

Br[C:2]1[CH:3]=[N:4][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[N:6][CH:7]=1.[C:24]([N:27]1[CH2:31][CH2:30][NH:29][C:28]1=[O:32])(=[O:26])[CH3:25]>>[C:24]([N:27]1[CH2:31][CH2:30][N:29]([C:2]2[CH:3]=[N:4][C:5]([C:8]([N:10]3[CH2:15][CH2:14][N:13]([C:16]4[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][N:17]=4)[CH2:12][CH2:11]3)=[O:9])=[N:6][CH:7]=2)[C:28]1=[O:32])(=[O:26])[CH3:25]

Participants

Reactant 2

HCID 79350N-Acetylimidazolidinone

HCID 71252096HCID 71252096, compound

Product 1

HCID 71253031HCID 71253031, compoundYield 8.7%

Procedure

Using (5-bromopyrimidin-2-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (376 mg) described in Preparation Example 229 and 1-acetylimidazolidin-2-one (192 mg) and by the reaction and treatment in the same manner as in Example 511, the title compound (37 mg) was obtained.

Sources & evidence

ORD record: ord-d2fef2da6d7c4609a8add08638fa572b
Source dataset: uspto-grants-2014_08
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08816079B2

Reaction notes

Loading…